Posts Tagged: webinar

miRNAs+Barcodes_V01

Webinar highlights – Maximizing miRNA-seq success from liquid biopsy samples

Development of markers that facilitate earlier and non-invasive diagnosis is a primary goal of disease research. This is where microRNAs come in. Studies have indicated that the expression levels of these non-coding RNA molecules are altered in disease states, including cancer and neurodegeneration. Evidence of their presence in biofluids means that their potential as important… Read article →


Live qPCR webinar

Live webinar! The importance of controls and novel solutions for successful real-time qPCR

Reverse transcription quantitative PCR (RT-qPCR) is one of the most widely used methods for gene quantification today because it offers numerous advantages. High sensitivity, accuracy, speed and specificity are the key benefits that have made it a gold standard for gene expression analysis. However, a number of critical factors are involved during the various steps… Read article →


Biogenesis

Eliminating contaminants in miRNA-seq libaries just got easier

microRNA sequencing is not only useful for finding novel microRNAs and detecting isomiRs; it’s also an attractive method for miRNA expression profiling, particularly when combined with molecular indexing to boost quantification accuracy (see our previous post, Barcodes in NGS: sample vs molecular). But preparing a library to sequence purely microRNAs can be difficult due to contaminating… Read article →


5214_QC_Workflow_0768_700x233 2

Join our webinar: State-of-the-art NGS library quality control solutions

Next-generation sequencing (NGS) is revolutionizing life science research and healthcare. The advent of multiple platforms has opened the doors to increased throughput, speed, sensitivity and flexibility, providing researchers with valuable insights at an unprecedented rate. While recent technological developments have made NGS more accessible to smaller labs, many barriers to implementation still remain. NGS workflows… Read article →


BreastCancer_700x233

New webinar: HER2, CTCs and tumor stemness

About 20–30% of breast cancer tumors overexpress the oncogene human epidermal growth factor receptor 2 (HER2), which – if not treated with a targeted anti-HER2 regimen – leads to higher aggressiveness and mortality. Recently, a number of studies have shown that expression of HER2 in circulating tumor cells (CTCs) varies compared to expression in primary tumors…. Read article →